Healthcare Startup Investments: Flushed out with $500 Million in Fund III at Lorient
Lorient Capital Successfully Closes $500 Million Healthcare Fund III
Lorient Capital, a venture firm dedicated to supporting companies that improve the healthcare system and create sustainable value, has announced the successful closure of its third healthcare-focused fund, Lorient Healthcare Fund III. The fund surpassed its initial $350 million target, raising a total of $500 million in commitments.
Co-Managing Partners David Berman and Jordan Broome expressed their gratitude to existing partners and new investors for their support. They stated that this fund is a significant advancement in Lorient's mission to support companies improving the healthcare system and creating long-term, sustainable value.
Lorient aims to improve clinical outcomes, workforce efficiency, and access to care. To achieve this, the firm uses a combination of sector expertise, operational capabilities, and a proprietary technology platform called Morpheus. Morpheus provides tools, insights, and capabilities beyond capital to portfolio companies, allowing them to scale effectively and deliver better care.
Jordan Broome mentioned Morpheus as Lorient's tool for accelerating transformation in the healthcare sector. He emphasized that healthcare investing can drive both strong returns and meaningful impact.
Lorient partners with founder-led, mid-market healthcare companies. The firm focuses on areas like consumer-directed healthcare, post-acute care, and behavioral health. The specific new investors in Lorient Healthcare Fund III who made an investment in a founder-led, mid-sized healthcare company supported by Lorient Capital were not specified in the statement.
Lorient has a track record of 20 platform investments and over 75 add-on acquisitions. Co-Managing Partners David Berman and Jordan Broome stated that Fund III reinforces Lorient's mission and is a significant step forward in their efforts to improve the healthcare system.
The fund closed on June 30th. David Berman and Jordan Broome stated that Lorient's mission is to support companies that improve the healthcare system and create sustainable value. They expressed their excitement for the opportunities that lie ahead as they work with their portfolio companies to drive meaningful change in the healthcare industry.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant